ArticleAnnals of intensive care2026
Systematic review, meta-analysis, and meta-regression of the association of serial leukocyte counts in critically ill patients and mortality.
Article in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Serial leukocyte counts have been investigated as a prognostic marker in critical illness. Our aim was to explore which immune cell type (total leukocytes, neutrophils, lymphocytes or neutrophil: lymphocyte ration (NLR)) best predicted mortality in critically ill patients. To address this, we conducted a systematic review, meta-analysis, and meta-regression of studies published within the past 10 years, archived on PubMed and Embase. Only studies reporting immune cell counts in critically ill patients on admission and within the subsequent week were included. Meta-regression was conducted to assess the effect of illness severity (reflected by study mortality rate) and underlying diagnosis (with 'general ICU patients' as a reference group) on the difference between immune cell counts between survivors and non-survivors. Meta-analysis and meta-regression were performed using Stata (version 19.5, StataCorp) and data presented as mean difference with (95% confidence intervals). Results: Thirty studies including 26,441 reporting patient mortality were included. Neutrophil: lymphocyte ratio (NLR) best predicted mortality and was lower among survivors at on days 0-1 (-0.29 (-0.45 to -0.12), p = 0.001), 2-4 (-1.02 (-1.57 to -0.48), p < 0.001), and 5-7 (-0.69 (-1.00 to -0.38), p < 0.001). Lymphocyte count was higher at equivalent time points. Meta-regression of NLR suggest that heterogeneity between studies was partly explained by underlying illness severity on days 0-1 (mean difference decreases by 0.13 (0.05, 0.20) for a 10% increase in mortality, p = 0.001), but not at other time points. Underlying diagnosis did not explain heterogeneity between studies. We were unable to perform a meta-analysis investigating the association between leukocyte counts and secondary infections as only three studies reported this data. Conclusion: A higher NLR count was associated with increased mortality throughout the first week of critical illness. Further work is required to define of cut- off values using an ordinal scale of lymphocyte count that accurately reflects immune dysfunction and risk of mortality. PROSPERO registration number: : CRD42024514115.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.